Collegium Pharmaceutical, Inc. (COLL)
46.58
-0.32
(-0.68%)
USD |
NASDAQ |
Jan 16, 11:02
Collegium Pharmaceutical SG&A Expense (TTM): 280.25M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 162.44M |
| Intuitive Surgical, Inc. | 2.310B |
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Corcept Therapeutics, Inc. | 401.86M |
| Altimmune, Inc. | 22.68M |